28102508|t|Simvastatin Promotes Hematoma Absorption and Reduces Hydrocephalus Following Intraventricular Hemorrhage in Part by Upregulating CD36
28102508|a|We previously found that hematoma worsens hydrocephalus after intraventricular hemorrhage (IVH) via increasing iron deposition and aggravating ependymal cilia injury; therefore, promoting hematoma absorption may be a promising strategy for IVH. Recently, some investigations imply that simvastatin has the ability of accelerating hematoma absorption. Thus, this study was designed to examine the efficacy of simvastatin for IVH in rats. Intracerebral hemorrhage with ventricular extension was induced in adult male Sprague-Dawley rats after autologous blood injection. Simvastatin or vehicle was administered orally at 1 day after IVH and then daily for 1 week. MRI studies were performed to measure the volumes of intracranial hematoma and lateral ventricle at days 1, 3, 7, 14, and 28 after IVH. Motor and neurocognitive functions were assessed at days 1 to 7 and 23 to 28, respectively. Iron deposition, iron -related protein expression, ependymal damage, and histology were detected at day 28. Expression of CD36 scavenger receptor (facilitating phagocytosis) was examined at day 3 after IVH using western blotting and immunofluorescence. Simvastatin significantly increased hematoma absorption ratio, reduced ventricular volume, and attenuated neurological dysfunction post- IVH. In addition, less iron accumulation and more cilia survival was observed in the simvastatin group when compared with the control. What's more, higher expression of CD36 was detected around the hematoma after simvastatin administration. Simvastatin significantly enhanced brain hematoma absorption, alleviated hydrocephalus, and improved neurological recovery after experimental IVH, which may in part by upregulating CD36 expression. Our data suggest that early simvastatin use may be a novel therapy for IVH patients.
28102508	0	11	Simvastatin	T103	UMLS:C0074554
28102508	21	29	Hematoma	T038	UMLS:C0018944
28102508	53	66	Hydrocephalus	T038	UMLS:C0020255
28102508	77	104	Intraventricular Hemorrhage	T038	UMLS:C0240059
28102508	116	128	Upregulating	T038	UMLS:C0041904
28102508	129	133	CD36	T017	UMLS:C1366645
28102508	159	167	hematoma	T038	UMLS:C0018944
28102508	168	175	worsens	T033	UMLS:C1457868
28102508	176	189	hydrocephalus	T038	UMLS:C0020255
28102508	196	223	intraventricular hemorrhage	T038	UMLS:C0240059
28102508	225	228	IVH	T038	UMLS:C0240059
28102508	245	260	iron deposition	T038	UMLS:C0333596
28102508	277	286	ependymal	T017	UMLS:C0014472
28102508	287	292	cilia	T017	UMLS:C0008778
28102508	293	299	injury	T037	UMLS:C3263723
28102508	322	330	hematoma	T038	UMLS:C0018944
28102508	374	377	IVH	T038	UMLS:C0240059
28102508	420	431	simvastatin	T103	UMLS:C0074554
28102508	464	472	hematoma	T038	UMLS:C0018944
28102508	542	553	simvastatin	T103	UMLS:C0074554
28102508	558	561	IVH	T038	UMLS:C0240059
28102508	565	569	rats	T204	UMLS:C0086893
28102508	571	595	Intracerebral hemorrhage	T038	UMLS:C0475526
28102508	649	668	Sprague-Dawley rats	T204	UMLS:C0034715
28102508	703	714	Simvastatin	T103	UMLS:C0074554
28102508	718	725	vehicle	T103	UMLS:C0042444
28102508	730	749	administered orally	T058	UMLS:C0001563
28102508	765	768	IVH	T038	UMLS:C0240059
28102508	796	807	MRI studies	T058	UMLS:C3515983
28102508	838	845	volumes	T058	UMLS:C2700258
28102508	849	861	intracranial	T082	UMLS:C0524466
28102508	862	870	hematoma	T038	UMLS:C0018944
28102508	875	892	lateral ventricle	T082	UMLS:C0152279
28102508	927	930	IVH	T038	UMLS:C0240059
28102508	932	937	Motor	T038	UMLS:C0234130
28102508	942	966	neurocognitive functions	T038	UMLS:C3714634
28102508	1024	1039	Iron deposition	T038	UMLS:C0333596
28102508	1041	1045	iron	T103	UMLS:C0302583
28102508	1055	1073	protein expression	T038	UMLS:C1171362
28102508	1112	1120	detected	T033	UMLS:C0442726
28102508	1132	1142	Expression	T038	UMLS:C0017262
28102508	1146	1150	CD36	T017	UMLS:C1366645
28102508	1151	1169	scavenger receptor	T103	UMLS:C0074129
28102508	1184	1196	phagocytosis	T038	UMLS:C0031308
28102508	1202	1210	examined	T033	UMLS:C0332128
28102508	1226	1229	IVH	T038	UMLS:C0240059
28102508	1236	1252	western blotting	T058	UMLS:C0005863
28102508	1257	1275	immunofluorescence	T058	UMLS:C0079603
28102508	1277	1288	Simvastatin	T103	UMLS:C0074554
28102508	1313	1321	hematoma	T038	UMLS:C0018944
28102508	1372	1407	attenuated neurological dysfunction	T033	UMLS:C1709219
28102508	1414	1417	IVH	T038	UMLS:C0240059
28102508	1432	1454	less iron accumulation	T033	UMLS:C4021076
28102508	1464	1469	cilia	T017	UMLS:C0008778
28102508	1499	1510	simvastatin	T103	UMLS:C0074554
28102508	1569	1579	expression	T038	UMLS:C0017262
28102508	1583	1587	CD36	T017	UMLS:C1366645
28102508	1592	1600	detected	T033	UMLS:C0442726
28102508	1612	1620	hematoma	T038	UMLS:C0018944
28102508	1627	1638	simvastatin	T103	UMLS:C0074554
28102508	1639	1653	administration	T058	UMLS:C1533734
28102508	1655	1666	Simvastatin	T103	UMLS:C0074554
28102508	1690	1695	brain	T017	UMLS:C0006104
28102508	1696	1704	hematoma	T038	UMLS:C0018944
28102508	1717	1741	alleviated hydrocephalus	T038	UMLS:C0020255
28102508	1747	1755	improved	T033	UMLS:C0184511
28102508	1769	1777	recovery	T038	UMLS:C2004454
28102508	1797	1800	IVH	T038	UMLS:C0240059
28102508	1823	1835	upregulating	T038	UMLS:C0041904
28102508	1836	1840	CD36	T017	UMLS:C1366645
28102508	1841	1851	expression	T038	UMLS:C0017262
28102508	1881	1892	simvastatin	T103	UMLS:C0074554
28102508	1912	1919	therapy	T058	UMLS:C0087111
28102508	1924	1927	IVH	T038	UMLS:C0240059